BillionToOne, Inc. Class A BLLN
NASDAQ · United States · Health Services
$106.44-11.74 (-9.93%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
BillionToOne has delivered a strong year to date gain, which puts fresh focus on whether the current share price lines up with the cash the business is expected to generate over time. With the valuation lens firmly on its cash flows, you need to ask whether the recent move reflects sustainable fundamentals or simply enthusiasm. The stock is up 30.0% year to date, which raises the stakes on whether today's valuation is adequately supported by the cash it can produce. The business model, which...
Key TakeawaysNo-Headline Rally: BillionToOne stock jumped 12% to $116 on Tuesday, September 22, without a company release, stretching a run that began near $100 on September 14. Insiders Took Profits: The CEO and general counsel sold ~60K shares for ~$6.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.